Discounted Cash Flow (DCF) Analysis Levered
Healthcare Special Opportunities Fu... (MDS-UN.TO)
$11.84
+0.53 (+0.00%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
| Revenue | 8.23 | 5.15 | 5.82 | 2.12 | 1.53 | 1.09 | 0.77 | 0.55 | 0.39 | 0.28 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (%) | ||||||||||
| Operating Cash Flow | 29.58 | 11.50 | 3.35 | 1.85 | 3.72 | 2.11 | 1.50 | 1.07 | 0.76 | 0.54 |
| Operating Cash Flow (%) | ||||||||||
| Capital Expenditure | - | - | - | - | - | - | - | - | - | - |
| Capital Expenditure (%) | ||||||||||
| Free Cash Flow | - | - | - | - | - | 2.11 | 1.50 | 1.07 | 0.76 | 0.54 |
Weighted Average Cost Of Capital
| Share price | $ 11.84 |
|---|---|
| Beta | 0.000 |
| Diluted Shares Outstanding | 2.63 |
| Cost of Debt | |
| Tax Rate | 3.10 |
| After-tax Cost of Debt | -% |
| Risk-Free Rate | |
| Market Risk Premium | |
| Cost of Equity | 4.542 |
| Total Debt | - |
| Total Equity | 31.14 |
| Total Capital | - |
| Debt Weighting | - |
| Equity Weighting | - |
| Wacc |
Build Up Free Cash Flow
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
| Revenue | 8.23 | 5.15 | 5.82 | 2.12 | 1.53 | 1.09 | 0.77 | 0.55 | 0.39 | 0.28 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 29.58 | 11.50 | 3.35 | 1.85 | 3.72 | 2.11 | 1.50 | 1.07 | 0.76 | 0.54 |
| Capital Expenditure | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | 2.11 | 1.50 | 1.07 | 0.76 | 0.54 |
| WACC | ||||||||||
| PV LFCF | - | - | - | - | - | |||||
| SUM PV LFCF | - |
Terminal Value
| Growth in perpetuity method: | |
|---|---|
| Long-term growth rate | |
| WACC (%) | - |
| Free cash flow (t + 1) | 0.55 |
| Terminal Value | - |
| Present Value of Terminal Value | - |
Intrinsic Value
| Enterprise Value | - |
|---|---|
| Net Debt | -3.33 |
| Equity Value | - |
| Shares Outstanding | 2.63 |
| Equity Value Per Share | - |